Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 28, 2020; 26(28): 4170-4181
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4170
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4170
Placebo group, n = 120 | BLWTG group, n = 118 | P value | |
Baseline | 4.63 ± 0.73 | 4.61 ± 0.72 | 0.8748 |
Week 1 | 4.43 ± 1.17 | 4.03 ± 1.28 | 0.0125 |
Week 2 | 3.65 ± 1.63 | 3.2 ± 1.59 | 0.0335 |
Week 3 | 3.67 ± 1.42 | 2.81 ± 1.46 | < 0.0001 |
Week 4 | 3.45 ± 1.48 | 2.38 ± 1.7 | < 0.0001 |
Week 5 | 3.23 ± 1.75 | 1.84 ± 1.71 | < 0.0001 |
Week 6 | 3.19 ± 1.56 | 1.32 ± 1.5 | < 0.0001 |
- Citation: Wen YD, Lu F, Zhao YP, Wang P, Yang Q, Li JX, Li HZ, Chi LL, Zhou ZH, Tang YP, Xu JK, Zhao Y, Tang XD. Epigastric pain syndrome: What can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules. World J Gastroenterol 2020; 26(28): 4170-4181
- URL: https://www.wjgnet.com/1007-9327/full/v26/i28/4170.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i28.4170